Drug development

#Drug delivery #Drug development #iiCON: Infection Innovation Consortium

iiCON launches new platform for long-acting medicines  

The Infection Innovation Consortium: iiCON has launched a new agreement with the Centre of Excellence for Long-Acting Therapeutics (CELT) at the University of Liverpool that will enable iiCON partners and collaborators to access the expertise and capability at CELT.  CELT is a research centre focused on the… Read More

#News

#Drug development #Drug discovery #Interview #Sitting Down With #The Jackson Laboratory #Vodcast

Vodcast: Dr Adriano Flora, The Jackson Laboratory

The latest sponsored DDW Sitting Down With vodcast features Dr Adriano Flora, Director of Business Development at The Jackson Laboratory (JAX). He discusses alternatives to non-human primates, the key benefits of this, and what impact will they have on the future of drug development. Moreover, he answers questions on… Read More

#Videos

#Collaboration #Drug development #Drug discovery #Partnership

Six March 2024 deals advancing drug discovery

Allogene Therapeutics and Arbor Biotechnologies Biotechnology companies Allogene Therapeutics and Arbor Biotechnologies entered a non-exclusive, global gene editing licensing agreement for use of Arbor’s proprietary CRISPR gene-editing technology in Allogene’s AlloCAR T platform for the treatment of autoimmune disease (AID). “The potential for CAR T as… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Guide

DDW Cell & Gene Therapy Guide 2024

Download the exclusive Guide and read about: Where is the global innovation in CGT and what opportunities is it creating? What does the CGT sector need to overcome challenges and get to market faster? Does the CGT sector have the skills required to ensure future success and of not, how… Read More

#DDW eBooks #DDW Guides

#Drug development #Drug discovery #International Women's Day

IWD 2024: Eight women taking the lead in drug discovery

For International Women’s Day (IWD), Diana Spencer highlights DDW interviews with eight inspirational women leaders in drug discovery and development. Stefanie Dedeurwaerdere, UCB Stefanie Dedeurwaerdere is Global Strategy Lead for Pipeline Development in Global Epilepsy & Rare Syndromes at UCB. In her day-to-day role, she is responsible for the development… Read More

#Exclusive Content

#Assay development optimisation & technology #Assays #Collaborative Drug Discovery (CDD) #Drug development #Drug discovery

How improved assay analysis benefits early drug discovery

DDW Editor Reece Armstrong speaks to Abraham Wang, Head of Marketing at Collaborative Drug Discovery (CDD) about annotated assays and the advantages they bring to research teams. RA: What advantages can better analysis into assays bring to drug developers? AW: Better analysis into assays offers a multitude of advantages, including… Read More

#Exclusive Content

Sustainability concept
#Drug development #Drug discovery #Environmental impact #Guide #Lab of the future #Sustainability

Improve sustainability without compromising on quality

A new Feature Note is now available entitled ‘Sustainability in the Lab: A Step-by-Step Guide‘, brought to you by PHCbi. Download the guide to gain insights on the steps you can take to achieve a more sustainable lab without compromising quality or performance. Learn about: Conducting an assessment Choosing… Read More

#News

#Drug development #Drug discovery #Environmental impact #Guide #Lab of the future #Sustainability

Sustainability in the Lab: A Step-by-Step Guide

Download this guide to gain insights on the steps you can take to achieve a more sustainable lab without compromising quality or performance. Learn about: Conducting an assessment Choosing the right equipment Conserving water and reducing waste Engaging and educating your team… Read More

#Resources

Bill & Melinda Gates Foundation
#Bill & Melinda Gates Foundation #Drug development #Drug discovery #Finance #Funding #Mouse models #PhaSER Biomedical (PhaSER)

$2.3m Gates Foundation grant to accelerate global drug discovery 

Edinburgh-based PhaSER Biomedical (PhaSER) has received a Bill & Melinda Gates Foundation grant totalling $2.3m to continue its work in accelerating drug discovery and development.   PhaSER will provide 8HUM transgenic mouse models, humanised for key pathways involved in the metabolism and disposition of drugs, to all the… Read More

#News

Researchers in a lab
#Drug development #Gene therapy #iPSC #Preclinical development #Webinar

How iPSC derived cells can support drug and gene therapy development

DDW recently hosted a webinar ‘Discover how iPSC derived cells can be used to support the development of drug and gene therapies’, supported by DefiniGEN. The event outlined how iPSC derived cells can be used to advance the efficiency and efficacy of disease modelling and covered topics including functionality, modelling… Read More

#Exclusive Content

business deal
#Acquisition #Biotech #Drug development #Investment #Mergers and acquisitions

Novo Holdings acquires Catalent for $16.5 billion 

Catalent and Novo Holdings, a holding and investment company that manages the assets and wealth of the Novo Nordisk Foundation, have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion.  Novo Holdings will acquire… Read More

#News

Miami skyline
#Advanced Therapies #Cell and gene therapy #Drug development #Manufacturing #Viral vectors

What challenges does the advanced therapies sector face? 

Over the three days of Advanced Therapies Week (ATW) 2024 in Miami, Florida, US, 16-19 January 2024, DDW’s Megan Thomas heard from attendees about the obstacles the sector needs to overcome to succeed.   Viral vector manufacturing   At the Advanced Therapies Awards ceremony, Dr Luigi Naldini, Director of the San Raffaele… Read More

#Exclusive Content #Opinion #Regulatory

384-well microplate
#Aurora Microplates #Drug development #Drug discovery #Lab technology

High-performance microplates for discovery sciences

This paid-for advertorial by Aurora Microplates appeared in DDW Volume 25 – Issue 1, Winter 2023/2024 Aurora Microplates is 100% focused on making the highest quality, highest performing microplates available. Aurora uses the best materials, the cleanest and most precise moulding operations and facilities to deliver high-performance microplates in a timely… Read More

#Exclusive Content

Pain killers
#Drug development #Ensysce Biosciences #Opioids #Painkillers #Public health

In Conversation With: Dr Lynn Kirkpatrick, Ensysce Biosciences

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dr Lynn Kirkpatrick, CEO… Read More

#News

#Drug development #Drug discovery #Guide #Therapeutic Antibodies

DDW Therapeutic Antibody Guide 2024

Download the exclusive Guide and read about: The global innovation in therapeutic antibody development and the opportunities being created What does the therapeutic antibody sector need to overcome challenges and get to market faster? Industry insight and forecasts… Read More

#DDW eBooks #DDW Guides

#Biopharmaceuticals #Clarivate #Drug development #Drug discovery #Market reporting

Thirteen potential blockbuster drugs to watch in 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. They include therapeutics for conditions including breast cancer, haemophilia A, sickle cell disease, Crohn’s disease, ulcerative colitis, respiratory syncytial virus (RSV) and multiple myeloma, among others. The predictions were… Read More

#News #Trending News #Trends & Analysis